mRNA Process Development and Manufacturing Summit Europe

Memo

Welcome to the Inaugural mRNA Process Development and Manufacturing Summit Europe Accelerating mRNA Drug Substance Process Scale Up and Manufacturing in Europe Built with biopharmaceutical industry insights, this conference is the only forum in Europe that will unite KOLs to delve deep into the critical challenges associated with mRNA manufacturing. The summit will uncover how to overcome the bottlenecks associated with scaling up, drug substance, analytics, purification, 5' capping, and regulation. With 16+ pioneering speakers from large pharma, innovative biotech, and key academics, join us in Frankfurt to explore the future of manufacturing scalable mRNA therapeutics and vaccines from bench to bedside and using emerging tools and technologies. Hear from CureVac, BioNTech SE, AstraZeneca, Genentech, Roche and more! Access the Full Event Guide to learn more https://ter.li/k6nrij URLs:Website: https://go.evvnt.com/1455970-0?pid=5569 Brochure: https://go.evvnt.com/1455970-2?pid=5569  Date and Time: On Tue, Apr 18, 2023 ( 9:00 AM) - Thu, Apr 20, 2023 ( 5:00 PM) Venue details: Sheraton Offenbach Hotel, 111 Berliner Straße, Offenbach am Main, Hessen, 63065, Germany Prices:Full Access Pass: Conference + 2 Workshops | Drug Developer: EUR 2796.00,Conference Only | Drug Developer: EUR 1899.00,Full Access Pass: Conference + 2 Workshops | Academic/ NFP: EUR 2096.00,Conference Only | Academic/ NFP: EUR 1499.00 Speakers: Andreas Kuhn SVP - RNA Biochemistry and Manufacturing, BioNTech SE, Anna Sarnefalt CMC Lead, Coalition for Epidemic Preparedness Innovations, Camilla Foged Professor of Vaccine Design and Delivery, University of Copenhagen, Eivor Ornskov Principal Scientist, AstraZeneca, Elaine Peters Director - Cell and Gene Therapy Analytical Capabilities, Genetech, Frank Eggert Associate Director Cap Technology, BioNTech SE, Harris Makatsoris Professor of Sustainable Manufacturing Systems, King's College London, Ike James Head of Technology Transfer, Medicines Patent Pool, Jose Castillo CEO, Quantoom Biosciences, Lena Wicke Senior Director RNA Process Development, BioNTech SE, Mark Dickman Professor, University of Sheffield, Michael Thommen Senior Scientist - Early Process Development and Innovation Projects CureVac, Mostafa Nakach Global Head of Process Engineering for Biologic Drug Development, Sanofi, Roland Pach Global Expert - Cell Gene Therapy, Analytics CMC, Roche, Steve Pascolo Professor, University Hospital Zurich, Taylor Scott Senior Scientist Process Development, GeneLeap BioTech, Tilmann Roos Senior Director of Technical Solution, CureVac